These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1678669)

  • 1. Node negative breast cancer: the prognostic value of DNA ploidy for long-term survival.
    Yuan J; Hennessy C; Corbett IP; Dykin R; Givan AL; Shenton BK; Henry JA; Wright C; Lennard TW
    Br J Surg; 1991 Jul; 78(7):844-8. PubMed ID: 1678669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
    Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
    Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour DNA ploidy as an independent prognostic factor in breast cancer.
    Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Koivula T
    Br J Cancer; 1987 Nov; 56(5):637-42. PubMed ID: 3426929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting outcome for patients with node negative breast cancer: a comparative study of the value of flow cytometry and cell image analysis for determination of DNA ploidy.
    Yuan J; Hennessy C; Givan AL; Corbett IP; Henry JA; Sherbet GV; Lennard TW
    Br J Cancer; 1992 Mar; 65(3):461-5. PubMed ID: 1348424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of age on the DNA ploidy levels of breast tumours.
    Taylor IW; Musgrove EA; Friedlander ML; Foo MS; Hedley DW
    Eur J Cancer Clin Oncol; 1983 May; 19(5):623-8. PubMed ID: 6683634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    Int J Clin Oncol; 2001 Aug; 6(4):177-82. PubMed ID: 11706555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.
    Noguchi M; Taniya T; Ohta N; Koyasaki N; Miyazaki I; Mizukami Y
    Breast Cancer Res Treat; 1991 Sep; 19(1):23-31. PubMed ID: 1661623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between DNA ploidy and survival in patients with primary breast cancer.
    Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
    Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
    Winter K; Eidtmann H; Jonat W
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human breast cancer: prognostic significance of the c-erbB-2 oncoprotein compared with epidermal growth factor receptor, DNA ploidy, and conventional pathologic features.
    Gasparini G; Gullick WJ; Bevilacqua P; Sainsbury JR; Meli S; Boracchi P; Testolin A; La Malfa G; Pozza F
    J Clin Oncol; 1992 May; 10(5):686-95. PubMed ID: 1349034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-erbB-2 oncoprotein overexpression identifies a subgroup of estrogen receptor positive (ER+) breast cancer patients with poor prognosis.
    Pinto AE; André S; Pereira T; Nóbrega S; Soares J
    Ann Oncol; 2001 Apr; 12(4):525-33. PubMed ID: 11398888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma.
    Bracko M; Us-Krasovec M; Cufer T; Lamovec J; Zidar A; Goehde W
    Anal Quant Cytol Histol; 2001 Feb; 23(1):56-66. PubMed ID: 11233744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.
    Bergers E; Baak JP; van Diest PJ; Willig AJ; Los J; Peterse JL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J; van Gorp LH
    Mod Pathol; 1997 Aug; 10(8):762-8. PubMed ID: 9267817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.